Cencora Inc. (COR)vsPACCAR Inc (PCAR)
COR
Cencora Inc.
$327.27
+2.08%
HEALTHCARE · Cap: $63.59B
PCAR
PACCAR Inc
$115.80
+1.29%
INDUSTRIALS · Cap: $58.51B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 1045% more annual revenue ($325.78B vs $28.44B). COR leads profitability with a 50.0% profit margin vs 8.3%. COR appears more attractively valued with a PEG of 0.78. COR earns a higher WallStSmart Score of 62/100 (C+).
COR
Buy62
out of 100
Grade: C+
PCAR
Hold46
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-43.9%
Fair Value
$254.20
Current Price
$327.27
$73.07 premium
Margin of Safety
-327.9%
Fair Value
$30.26
Current Price
$115.80
$85.54 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 134 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 118.0%
Large-cap with strong market position
Growing faster than its price suggests
Large-cap with strong market position
Areas to Watch
Premium valuation, high expectations priced in
Trading at 33.4x book value
Negative free cash flow — burning cash
Weak financial health signals
Revenue declined 13.7%
Earnings declined 35.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 50.0% and operating margin at 118.0%. PEG of 0.78 suggests the stock is reasonably priced for its growth.
Bull Case : PCAR
The strongest argument for PCAR centers on Market Cap. PEG of 1.13 suggests the stock is reasonably priced for its growth.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Price/Book, Free Cash Flow.
Bear Case : PCAR
The primary concerns for PCAR are Piotroski F-Score, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
COR profiles as a mature stock while PCAR is a value play — different risk/reward profiles.
PCAR carries more volatility with a beta of 1.05 — expect wider price swings.
COR is growing revenue faster at 5.5% — sustainability is the question.
PCAR generates stronger free cash flow (778M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 46/100), backed by strong 50.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
PACCAR Inc
INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA
PACCAR Inc is an American Fortune 500 company and counts among the largest manufacturers of medium- and heavy-duty trucks in the world. PACCAR is engaged in the design, manufacture and customer support of light-, medium- and heavy-duty trucks under the Kenworth, Peterbilt, Leyland Trucks, and DAF nameplates. PACCAR also designs and manufactures powertrains, provides financial services and information technology, and distributes truck parts related to its principal business.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?